Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Glenmark shines with arm receiving USFDA's final approval for Hydrocortisone Valerate Cream

15-Oct2018

Glenmark shines with arm receiving USFDA's final approval for Hydrocortisone Valerate Cream

Glenmark Pharmaceuticals is currently trading at Rs. 610.00, up by 9.15 points or 1.52% from its previous closing of Rs. 600.85 on the BSE.

The scrip opened at Rs. 606.90 and has touched a high and low of Rs. 615.45 and Rs. 596.35 respectively. So far 57685 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 711.55 on 10-Sep-2018 and a 52 week low of Rs. 483.60 on 30-May-2018.

Last one week high and low of the scrip stood at Rs. 615.45 and Rs. 575.00 respectively. The current market cap of the company is Rs. 17174.16 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 38.19% and 15.28% respectively.Glenmark Pharmaceuticals' subsidiary -- Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Hydrocortisone Valerate Cream USP, 0.2%, a generic version of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc.

According to IQVIA sales data for the 12-month period ending August 2018, the Westcort Cream, 0.2% market achieved annual sales of approximately $17.0 million.
The company's current portfolio consists of 139 products authorized for distribution in the US marketplace and 60 ANDA's pending approval with the USFDA. In addition to these internal filings, the compnay continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Related News

View all news

Mindtree rises on crossing $1 billion in annual revenue

Mindtree is currently trading at Rs. 983.85, up by 11.70 points or 1.20% from its previous closing of Rs. 972.15 on the BSE.The scrip opened at Rs. 977.00 and has touched a high and low of Rs. 986.45 and......

INDSIL Hydro Power trades in green on the bourses

Indsil Hydro Power and Manganese is currently trading at Rs. 60.00, up by 0.35 points or 0.59% from its previous closing of Rs. 59.65 on the BSE.The scrip opened at Rs. 60.40 and has touched a high and......

SpiceJet flies high on the bourses

Spicejet is currently trading at Rs. 142.10, up by 9.40 points or 7.08 % from its previous closing of Rs. 132.70 on the BSE.The scrip opened at Rs. 144.00 and has touched a high and low of Rs. 152.60 and......

Top News

View all news

Lupin seeks more time from commerce ministry to complete project in Indore SEZ

Lupin has sought more time from the commerce ministry to complete its project, with proposed investment of Rs 205.69 crore, in the Indore Special Economic Zone (SEZ). The company is setting up its pharma......

Tata Sponge Iron to shift its registered office to Kolkata

Tata Sponge Iron has decided to shift its registered office from Keonjhar in Odisha to Kolkata, subject to the approval of the members of the company and other regulatory authorities. The company has also......

GVK Power's arms ink pact with ADIA, NIIF

GVK Power and Infrastructure's subsidiaries -- GVK Airports Developer (GVKADL) and GVK Airport Holdings (GVKAHL) have signed a term sheet and exclusivity agreement with Abu Dhabi Investment Authority (ADIA)......